BioCentury
ARTICLE | Finance

A fever for infectious

Why GV picked Spero for its first infectious disease investment

March 10, 2017 6:51 PM UTC

A two-year search for an infectious disease investment led GV to Spero Therapeutics LLC, whose platform technology, management and investor syndicate proved to be the winning combination.

“We had been looking in the antibiotics space for a couple years, trying to figure out exactly when and where to participate,” GV’s Krishna Yeshwant told BioCentury. ...